G. Farfel

B. Galer, A. Gammaitoni, G. Farfel, 2022, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growth

E. Wirrell, O. Devinsky, B. Galer, 2021, Epilepsy & Behavior.

Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.

M. Hegel, R. Maddock, J. Himmelhoch, 2001, The Journal of clinical psychiatry.

Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.

L. Seiden, G. Farfel, 1995, The Journal of pharmacology and experimental therapeutics.

Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment

I. Scheffer, G. Gioia, P. Isquith, 2022, Epilepsy & Behavior.

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome

I. Scheffer, L. Lagae, B. Galer, 2022, JAMA neurology.

A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects

Brooks M. Boyd, B. Galer, A. Gammaitoni, 2018, International journal of clinical pharmacology and therapeutics.

Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndrome

G. Gioia, P. Isquith, E. Wirrell, 2021, Epilepsy & Behavior.

Fenfluramine modulates the anti-amnesic effects induced by sigma-1 receptor agonists and neuro(active)steroids in vivo

Brooks M. Boyd, B. Galer, A. Gammaitoni, 2022, Epilepsy & Behavior.

Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan.

L. Seiden, G. Farfel, 1995, The Journal of pharmacology and experimental therapeutics.

Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.

Charles R Marmar, C. Marmar, D. Baker, 2007, The Journal of clinical psychiatry.

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.

B. Rothbaum, J. Davidson, B. Kolk, 2001, Archives of general psychiatry.

Efficacy and Safety of Sertraline Treatment of Posttraumatic Stress Disorder

B. Rothbaum, K. Brady, D. Baker, 2007 .

Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder

B. Rothbaum, M. Hegel, J. Davidson, 2003 .

Characterizing the effects of sertraline in post-traumatic stress disorder

J. Davidson, C. Clary, G. Farfel, 2002, Psychological Medicine.

Sertraline and posttraumatic stress disorder: Results of 24 weeks of open-label sertraline followed by a 28-week discontinuation study

B. Rothbaum, J. Davidson, G. Farfel, 2000, European Neuropsychopharmacology.

Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey

L. Seiden, M. Kleven, B. Perry, 1992, Brain Research.

Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.

S. Kornstein, G. Farfel, R. Fayyad, 2006, The Journal of clinical psychiatry.

A randomized controlled trial of ganaxolone in posttraumatic stress disorder

M. Stein, R. Raman, A. Rasmusson, 2017, Psychopharmacology.

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study

I. Scheffer, L. Lagae, B. Galer, 2022, Epilepsia.

Fenfluramine Treatment Improves Everyday Executive Functioning in Patients with Lennox-Gastaut Syndrome: Analysis from a Phase 3 Clinical Trial

I. Scheffer, G. Gioia, B. Galer, 2021, Neuropediatrics.

Long-Term (2-Year) Safety and Efficacy of Adjunctive ZX008 (Fenfluramine Hydrochloride Oral Solution) for Dravet Syndrome: Interim Results of an Ongoing Open-Label Extension Study (4684)

E. Wirrell, B. Galer, M. Lock, 2020 .

The N-methyl-d-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine 3,4-methylenedioxymethamphetamine and p-chloroamphetamine

L. Seiden, G. Farfel, G. Vosmer, 1992, Brain Research.

Double-blind flexible dose multicenter study of sertraline and placebo in outpatients with post-traumatic stress disorder

K. Brady, D. Baker, G. Farfel, 1998, European Neuropsychopharmacology.

663. An Examination of the Mechanism of Action of Fenfluramine in Dravet Syndrome: A Look beyond Serotonin

Brooks M. Boyd, B. Galer, A. Gammaitoni, 2017, Biological Psychiatry.

Long-Term Cardiovascular Safety of Fenfluramine HCl in the Treatment of Dravet Syndrome: Interim Analysis of an Open-Label Safety Extension Study

Helen J. Cross, I. Scheffer, L. Lagae, 2019, Epilepsy & Behavior.

Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 years

E. Wirrell, N. Fountain, C. Harden, 2022, Epilepsia.

Fenﬂuramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome

G. Gioia, S. Auvin, R. Guerrini, 2022 .